|
J Biol Chem, Vol. 274, Issue 49, 34779-34784, December 3, 1999
p34Cdc2 Kinase Activity Is Excluded from the Nucleus
during the Radiation-induced G2 Arrest in HeLa Cells*
Gary D.
Kao,
W. Gillies
McKenna, and
Ruth J.
Muschel §
From the Department of Radiation Oncology and
Department of Pathology and Lab Medicine, University of
Pennsylvania, Philadelphia, Pennsylvania 19104
 |
ABSTRACT |
The progression of cells from
G2 into mitosis is blocked by exposure to
DNA-damaging agents such as ionizing radiation. This G2
delay is associated with reduced cyclin B1-specific associated histone
H1 kinase activity, increased inhibitory phosphorylation of
p34Cdc2, and depressed cyclin B1 levels in HeLa cells.
Induction of cyclin B1 or expression of Cdc2AF, a mutant
p34Cdc2 that lacks the sites of inhibitory phosphorylation,
only partially reverses the radiation-associated G2 delay,
although both maneuvers rapidly result in increased histone H1 kinase
activity. To account for the persistent G2 delay in the
face of active p34Cdc2 kinase, we determined the location
of the kinase activity. Although p34Cdc2 was active in the
cytoplasm, the nuclear p34Cdc2 was inactive. Irradiation
led to nuclear accumulation of the inactive tyrosine-phosphorylated
form of p34Cdc2, whereas the active form was seen in the
cytoplasm. At later times when cells had resumed cell cycle
progression, nuclear kinase activity was detectable. These results give
evidence of segregation of cytoplasmic and nuclear kinase activity
after DNA damage that has the effect of enhancing checkpoint control.
Shielding the nucleus from the potentially deleterious effects of
kinase activity after DNA damage may help irradiated human cancer cells
respond to irradiation.
 |
INTRODUCTION |
After exposure to ionizing radiation, eukaryotic cells arrest at
various points in the cell cycle (1-3). The most widely studied of
these checkpoints are those that are seen in the G1 and
G2 phases of the cycle (4, 5). The G1 delay
induced by ionizing radiation is entirely dependent upon p53, which
directs the transcription of p21waf1/cip1/sdi1 (6-8, 10). The
G2 block, however, appears to result from multiple
mechanisms. Induction of p53 can lead to a G2 arrest (9,
25); however, many malignant cells lack p53 function, as demonstrated
by the absence of a G1 arrest after radiation exposure, yet
these cells almost universally retain a G2 block. For
example HeLa cells, which lack functional wild type p53, show no
induction of p21 protein after exposure to ionizing radiation and no
G1 checkpoint but have a dose-dependent G2 delay (11, 12). Neither p21 nor p53 is required for the radiation-induced G2 delay, as cells derived from p21 or
p53 knockout mice or cells in which p53 is inactivated show equivalent
G2 delays after radiation (13-16).
Other factors have been implicated as components of the G2
block. Radiation results in transiently decreased
p34Cdc2/cyclin B1 kinase activity (17-24). The absolute
levels of p34Cdc2 protein are not altered after radiation
(18, 22), and thus, the decreased activity is regulated both through
levels of cyclin B1 as well as the inhibitory phosphorylation of
p34Cdc2/cyclin B complex. We have previously shown that
radiation results in cyclin B1 mRNA instability and decreased
cyclin B1 protein levels, which would prevent activation of
p34Cdc2 (4, 32, 40). We also found that restoration of
cyclin B1 expression after radiation can only partially abrogate the G2 delay (26). This indicates that there is a contribution
of decreased cyclin B1 to the G2 delay, but that other
factors must also be at play.
The contribution of the inhibitory phosphorylations of
p34Cdc2 to the G2 arrest has also been
evaluated. Jin et al. (38) induced expression of Cdc2AF, a
mutant form of Cdc2 that cannot undergo inhibitory phosphorylation.
This resulted in only partial abrogation of the G2 delay,
despite markedly increased p34Cdc2 activity. The
phosphorylation of p34Cdc2 is regulated in part by the
phosphatase Cdc25C, whose activity in turn is regulated by
phosphorylation. Radiation induces chk1 activity in yeast, which in
turn inhibits Cdc25C (63). A number of mammalian chk1 homologs have
been identified that interact with Cdc25C (43, 61). Therefore, neither
the ability to phosphorylate p34Cdc2 nor the regulation of
the levels of cyclin B1 individually appears to control the
G2 delay.
Nuclear localization of the cyclin B1/p34Cdc2 complex has
also been implicated both as a component of normal mitosis and as a component of the G2 delay (27, 29). The nuclear
localization of cyclin B1 in itself does not appear to be the sole
determinant of progression into mitosis. The cell cycle delay is not
abolished when cyclin B1 is introduced into the nucleus via
microinjection, expression of nuclear localization signal-tagged cyclin
B1 protein, or treatment with leptomycin B (which disrupts cyclin
B1-CRM1 interaction) (30). The delay was, however, abolished by
leptomycin B plus caffeine. We have shown that caffeine abolishes the
radiation-induced suppression of cyclin B expression (31), but caffeine
also has promiscuous effects on protein phosphorylation, which may also contribute to its cell cycle effects. It has been recently reported that expression of nuclear localization signal-tagged cyclin B1 and
Cdc2AF together led to nuclear envelope dissolution, accelerating the
normal cycle and the G2 delay. In this case, however,
normal cycling did not result but, instead, a mitotic catastrophe,
leaving the question of whether this procedure resembled normal
physiological processes.
We report here our efforts in investigating mechanisms underlying the
G2 delay after radiation. We find that despite cyclin B1
induction and the presence of significant levels of cyclin B1-associated kinase activity, cells remain partially blocked in
G2. We find that when cells are blocked in G2
after radiation, the cyclin B1-associated kinase activity is localized
in the cytoplasm for a substantial period of time. Nuclear kinase
activity is evident only when cells exit the G2 delay. We
find that expression of both cyclin B1 and Cdc2AF together increases
cytoplasmic kinase activity but is still insufficient to circumvent the
cellular compartmentalization of kinase activity and completely remove the G2 delay. These results help explain why induced
expression of cyclin B1 or Cdc2AF protein were not successful in
completely abrogating the G2 delay after irradiation. These
observations together highlight the presence of multiple distinct but
interrelated mechanisms of regulation of cell cycle progression after
exposure to DNA-damaging agents.
 |
MATERIALS AND METHODS |
Cell Culture and Synchronization--
Experiments described here
were performed with S21 cells (described in Ref. 26), which are a HeLa
clone stably transfected with a dexamethasone-inducible expression
vector encoding cyclin B1. Cells were grown and synchronized with
sequential thymidine and aphidicolin blocks and irradiated as described
previously (27). Radiation was delivered using a high dose rate cesium irradiator (12.84 Gy/min,1
confirmed by Fricke dosimetry). Control cells were always
mock-irradiated. Dexamethasone when added was at 1 µg/ml and 1 h
after irradiation.
For experiments involving transfections, 10 µg of plasmid (pECE-Cdc2
(cDNA coding for coding for wild type Cdc2 protein) or pECE-Cdc2AF
(p34Cdc2 with mutations replacing the threonine 14 and
tyrosine 15 with alanine and phenylalanine, respectively), both kindly
provided by Dr. F. McKeon) was used for transfection of 1 × 106 cells with LipofectAMINE (Life Technologies, Inc.)
following the manufacturer's instructions. LipofectAMINE with the
transfected plasmid was applied in serum-free medium. After 4-6 h,
aphidicolin (2 µg/ml) was added in serum-containing medium for
12 h. The aphidicolin was washed out, and cells were then
irradiated 3 h after the removal of aphidicolin. One h after
irradiation, dexamethasone was added (1 µg/ml). In the experiments
using caffeine (2 mM), it was added at the time of removal
of the aphidicolin 3 h before irradiation.
Immunoblotting and Protein Expression--
For immunoblotting,
100,000 cells were harvested in 400 µl of sample buffer (10%
glycerol, 2% SDS, 100 mM dithiothreitol, 50 mM
Tris, pH 6.8). 30 µl of each lysate was loaded per lane and separated
by electrophoresis on a 15% SDS-polyacrylamide gel before overnight
transfer to a nitrocellulose membrane (Bio-Rad). The cyclin B1 (Upstate
Biotechnology, Inc.), -tubulin (Sigma), or phosphotyrosine
p34Cdc2 antibodies (New England Biolabs) were used at
1:1000. Polyclonal anti-ataxia-telangiectasia protein (ATM) antibodies
was kindly provided by Dr. T. Yen. Incubation with the secondary
antibody, HRP-conjugated goat anti-mouse antibody, 1:2000 (Roche
Molecular Biochemicals), was performed in a solution of 2.5% powdered
milk in phosphate-buffered saline. Detection was performed by
chemoilluminescence (ECL, Amersham Pharmacia Biotech). Densitometry was
analyzed by NIH image software.
Nocodazole Trapping--
Cell cycle progression into mitosis was
analyzed via nocodazole trapping of synchronized cells as described in
(26, 22). Briefly, for each time point, nocodazole (0.04 µg/ml) was
added to duplicate plates 2-3 h after release from the aphidicolin
block. Thus the number of mitotic cells represent the cumulative total of all cells that have entered into mitosis at that time. At least 100 cells were evaluated for mitosis after staining with propidium iodide
using the Zeiss Axioplan microscope.
Cell Fractionation--
Cell fractionation was performed via a
modification of methods as described by Schreiber et al.
(33). Briefly, 1 million cells grown on 10-cm tissue culture dishes
(Fisher) were harvested by scraping with a rubber policeman. Cell
pellets were resuspended in 200 µl of hypotonic buffer (10 mM HEPES, pH7.9, 10 mM KCL, 0.1 mM
EDTA, 0.1 mM EGTA) incubated at 4 °C for 10 min, and
Nonidet P-40 added to a final concentration of 0.5%. Samples were
vortexed ×10 s and centrifuged at 800 rpm × 5 min to collect the
cytoplasmic fraction. The nuclear pellet was resuspended and incubated
in 200 µl of nuclear extract buffer (20 mM HEPES, pH 7.9, 0.4 M NaCl, 1 mM EDTA, 1 mM EGTA,
20% glycerol) for 30 min before centrifugation at 2000 rpm × 10 min to collect the nuclear fraction.
Histone H1 Kinase Assay--
Immunoprecipitation of cyclin
B1-specific histone H1 kinase (p34Cdc2) activity was
performed using anti-cyclin B1 antibody (Upstate Biotechnology) as
described by Pines and Hunter (34). Immunoprecipitated samples were
preincubated with HB buffer (25 mM MOPS, pH 7.2, 60 mM -glycerophosphate, 15 mM
p-nitrophenylphosphate, 15 mM MgCl2,
15 mM EGTA, 1 mM dithiothreitol, 0.1 mM sodium vanadate, 1% Triton X-100, 1 mM
phenylmethylsulfonyl fluoride, 20 µg/ml leupeptin, 40 µg/ml
aprotonin) at 37 °C for 5 min. 10 µl of KIN buffer (1 mg/ml
histone H1 (Roche Molecular Biochemicals), 200 µM
-labeled [32P]ATP in HB buffer) was then added and
incubated for a further 20 min. Finally, 2× lysis buffer was added,
and samples were boiled for 5 min and separated by 12%
SDS/polyacrylamide gel electrophoresis and detected by autoradiography.
Densitometry was performed with NIH Image software.
 |
RESULTS |
Effect of Induction of Cyclin B1 on p34Cdc2 Activity in
Irradiated Cells--
To ask whether the depression of cyclin B1 seen
after irradiation in HeLa cells contributes to the G2
delay, we had previously developed a HeLa cell clone (S21) carrying a
dexamethasone-inducible vector for cyclin B1 (26). Dexamethasone itself
affected neither cyclin B1 levels nor the cell cycle delay in the
absence of the expression vector. Treatment of stable clones carrying
the inducible vector with dexamethasone leads to elevated levels of
cyclin B1 as soon as 2 h after addition. Induction of cyclin B1 in
unirradiated cells had no discernable effect on the timing of
G2, whereas restoration of cyclin B1 levels in irradiated
cells shortened but did not eliminate the G2 delay.
To investigate the effect of induction of cyclin B1 on
p34Cdc2 kinase activity, we synchronized the S21 cells with
sequential thymidine and aphidicolin blocks (see "Materials and
Methods"), and 2 h after release from the aphidicolin block,
irradiated with 3 Gy. One h after irradiation, dexamethasone was added
to induce cyclin B1. Irradiation markedly diminished cyclin
B1-immunoprecipitable p34Cdc2 histone H1 kinase activity
(Fig. 1A, compare irradiated
versus unirradiated samples, 11 (lane 4 versus lane 12) and 13 (lane 6 versus lane
13) h after release from the aphidicolin block). The addition of
dexamethasone increased cyclin B1 levels (Fig. 1A) and
restored cyclin B1-p34Cdc2 kinase activity (lane
3). Despite the restoration of cyclin B1-p34Cdc2
kinase activity, however, cell cycle progression was only partially accelerated. At the 15-h time point, most of the unirradiated control
cells (79%) had entered mitosis, compared with only 2% of the
irradiated cells and 19% of the irradiated cells with induced cyclin
B1. These cumulative mitotic counts (Fig. 1B) indicated that
the cell cycle delay after irradiation was diminished but not abolished
by the induced expression of cyclin B1, despite overall levels of
cyclin B1-p34Cdc2 kinase activity that approximated levels
in unirradiated control cells.

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 1.
p34Cdc2 activity and cell cycle
progression after irradiation (IR) and induced
expression of cyclin B1. S21 cells containing the dexamethasone
(Dex)-inducible cyclin B1 expression vector were
synchronized sequentially with thymidine and aphidicolin, released from
the aphidicolin block, and irradiated 3 h after release (3 Gy) at
a time when 90% of the cells were in S phase. Dexamethasone or control
media was added 1 h after irradiation. Cells were harvested at the
indicated times after release from the aphidicolin block (time = 0 h) and analyzed for cyclin B1-p34Cdc2 histone H1
kinase activity, cyclin B1 protein, and cell cycle progression. The
cyclin B1 immunoblot was stripped and reprobed for tubulin protein as a
loading control. A shows the autoradiograph of the
phosphorylated histone H1 indicating p34Cdc2 kinase
activity and the immunoblots of cyclin B1 and tubulin. B
shows the cumulative mitotic counts performed in the presence of
nocodazole to prevent cells from re-entering G1
("nocodazole trapping"). Con, control.
|
|
p34Cdc2 Kinase Activity in Cytoplasmic and Nuclear
Fractions--
To understand why cyclin B1-p34Cdc2 kinase
activity might be ineffective in abolishing the G2 block,
we measured the kinase activity after separation into cytoplasmic and
nuclear fractions (Fig. 2). S21 cells
were synchronized and harvested either at the G1/S interface, in G2, unirradiated in G2, or
blocked in metaphase with nocodazole. Verification of the separation
between the nuclear and the cytoplasmic fractions was achieved by
immunoblotting parallel samples with anti- -tubulin (a cytoplasmic
protein) or anti-ataxia-telangiectasia protein (a nuclear protein)
(36). Nuclear and cytoplasmic compartments will be mixed in mitosis due
to the dissolution of the nuclear envelope, and mitotic cells arrested
by nocodazole had both markers in each fraction. There was little
contamination of the nuclear fraction with cytoplasm, although trace
nuclear material was found in the cytoplasm under the conditions used.
After irradiation, p34Cdc2 kinase activity was detectable
only in the cytoplasm of the irradiated cells, not in the nucleus, and
was diminished in amount compared with that of the unirradiated cells.
In unirradiated G2 cells, p34Cdc2 kinase
activity was detectable in both the cytoplasm and nucleus, whereas
activity was not detected in either compartment in G1/S cells.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 2.
Cytoplasmic and nuclear p34Cdc2
kinase activity after irradiation. S21 cells were synchronized
with thymidine and aphidicolin sequential blocks. Cells were harvested
at the G1/S interface (G1/S) immediately after
the final removal of aphidicolin. Irradiated (IR) cells were
synchronized and irradiated (IR, 10 Gy) 3 h after
release from aphidicolin and harvested 12 h after release.
Unirradiated G2 cells (G2) were synchronized,
mock-irradiated, and harvested 12 h after release when the
majority were in G2. Cells were placed into nocodazole
(Noco) treatment for 12 h after release from the
thymidine block at the same time as aphidicolin would have been
applied. All treatments were scheduled in order that all cells were
harvested and analyzed for kinase activity and protein at the same
time. All samples were fractionated into cytoplasmic and nuclear
fractions using the methods of Schreiber et al. (33).
Parallel samples were assayed for p34Cdc2 kinase activity
and immunoblotting. Samples were probed for tubulin and ATM protein, as
respectively cytoplasmic and nuclear markers.
|
|
We evaluated the effect of cyclin B1 induction on kinase activity in
irradiated cells (Fig. 3). At each time
point after irradiation, parallel samples were harvested for analysis
of kinase activity after fractionation into cytoplasmic and nuclear
components and analysis of cell cycle progression. Cyclin
B1-p34Cdc2 kinase activity was reduced in irradiated cells
compared with the unirradiated cells. Kinase activity in the nucleus
was not seen in the irradiated cells (Fig. 3A, compare
lanes 5 and 7). At 15 h, cytoplasmic cyclin
B1-p34Cdc2 kinase activity in the irradiated cells was
equivalent to that in unirradiated cells, but nuclear kinase activity
was still depressed. Induction of cyclin B1 resulted in levels of
cytoplasmic p34Cdc2 kinase activity that exceeded the
levels in unirradiated control cells, yet the nuclear
p34Cdc2 kinase activity was still depressed (compare
activity in lanes 3 and 5). Fig. 3B
shows in graphical form the densitometry values of the
p34Cdc2 kinase assays shown in Fig. 3A, showing
the dissociation of cytoplasmic from nuclear kinase activity after
irradiation and showing that nuclear, not cytoplasmic, kinase activity
correlated with progression into mitosis.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 3.
Effect of cyclin B1 induction on cytoplasmic
(Cyto) and nuclear (Nuc)
p34Cdc2 kinase activity. S21 cells were synchronized
and irradiated (IR) as described in Fig. 1. Dexamethasone
(Dex) was added at the time of irradiation. Synchronized
cells harvested at the indicated times after release were fractionated
into cytoplasmic and nuclear fractions and analyzed for cyclin
B1-p34Cdc2 activity, whereas duplicate samples were
analyzed for cell cycle progression. A shows the
autoradiograph of phosphorylated histone H1. B shows
densitometry values of autoradiographs of the kinase activity and the
proportion of cells progressing into mitosis measured by
nocodazole.
|
|
Effect of Expression of Cdc2AF and Cyclin B1 Protein--
Cdc2AF
is a mutant p34Cdc2 protein that lacks the inhibitory
phosphorylation sites at positions 14 and 15 (37-39). We irradiated synchronized cells that had been transfected with an expression vector
for Cdc2AF. As before, radiation resulted in markedly decreased cytoplasmic cyclin B1-p34Cdc2 activity (Fig.
4A, lanes 1 and
2) and no detectable nuclear cyclin B1-p34Cdc2
activity in the control cells. The induced expression of either cyclin
B1 or Cdc2AF led to increased cytoplasmic kinase activity but did not
effect an increase in nuclear activity (lanes 3 and 5). The induced expression of cyclin B1 and Cdc2AF together
led to a greater increase of cyclin B1-p34Cdc2 activity
than either alone, but still there was no increase in nuclear activity
(lane 4). Transfection of a vector coding for wild type
p34Cdc2 protein did not increase the cytoplasmic or the
nuclear cyclin B1-p34Cdc2 activity. Dexamethasone alone had
a negligible effect on nuclear cyclin B1-p34Cdc2 activity,
consistent with its lack of effect on cell cycle progression (Ref. 26
and data not shown).

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 4.
Compartmentalization of p34Cdc2
kinase activity after transfection of Cdc2AF or wild type Cdc2 and
induction of cyclin B1 expression. Cells were transfected with
pECE Cdc2AF (CDC2AF) or pECE wild type Cdc2
(CDC2) or mock-transfected as described under "Materials
and Methods." 4-6 h after the initiation of transfection,
aphidicolin (2 µg/ml) was applied for 12 h to partially
synchronize the cells and then washed out. Irradiation (IR,
3 Gy) was performed 3 h after release from aphidicolin, and
samples were harvested 6 h after irradiation. Caffeine was added
immediately before irradiation (Caff), whereas dexamethasone
(Dex) was added 1 h after irradiation. Cells were
fractionated, harvested, and assayed for p34Cdc2 kinase
activity as described previously. All samples were harvested at the
same time. The treatment groups are as indicated to the right of the
autoradiographs. A and B show different
experiments. Cyto, cytoplasmic; Nuc,
nuclear.
|
|
Localization and Expression of Tyrosine 15 Phosphorylated
p34Cdc2--
We determined the phosphorylation status of
p34Cdc2 in the nucleus and cytoplasm using an antibody
specific for the phosphotyrosine 15 form of p34Cdc2, which
has minimal cross-reactivity with unphosphorylated p34Cdc2.
Using this antibody, it has previously been reported that exposure of
yeast to DNA-damaging agents results in accumulation of
tyrosine-phosphorylated p34Cdc2 (45). Synchronized HeLa
cells were irradiated with 5 Gy, fractionated into cytoplasmic and
nuclear components, and assessed for tyrosine 15 p34Cdc2
protein at 7 h, when the control unirradiated cells would be in
G2 (7 h) and when virtually all irradiated cells would have accumulated in the G2 block, whereas unirradiated cells
would have completed mitosis (24 h) (Fig.
5). Irradiation led to marked nuclear
accumulation of tyrosine 15-phosphorylated p34Cdc2 protein
(Fig. 5A). At 24 h, unirradiated control cells have
already passed through mitosis and show slight accumulation of tyrosine 15-phosphorylated p34Cdc2. In contrast, irradiated cells
show marked nuclear accumulation of tyrosine 15 phosphorylated
p34Cdc2.

View larger version (46K):
[in this window]
[in a new window]
|
Fig. 5.
Accumulation and localization of tyrosine
15-phosphorylated p34Cdc2 after DNA damage.
Synchronized HeLa cells were prepared as described in Fig. 1. Cells
were treated with DNA-damaging agents 3 h after release from
aphidicolin. Control cells (Con) were mock-treated. In
A cells were irradiated (IR) with 5 Gy. Both
irradiated and unirradiated control cells were harvested at the
indicated times and separated into nuclear (Nuc) and
cytoplasmic (Cyto) fractions, followed by immunoblotting
with antiphosphotyrosine 15 antibody. In B, synchronized
cells were irradiated or treated with etoposide (Etop)
3 h after release. Etoposide treatment consisted of 20 µg/ml of
etoposide for 20 min before being washed off thoroughly with
phosphate-buffered saline. Caffeine (Caff, 2 mg/ml final
concentration) was added at the time of radiation or etoposide
treatment and was present in the media throughout the remainder of the
experiment. Nocodazole (Noco) was used at 20 ng/ml final
concentration and was added 3 h after release as well.
anti-Tyr-Pi, anti-phosphotyrosine 15 antibody. In
C, under conditions identical to B, the cell
cycle progression into mitosis was measured using nocodazole trapping
as described in the preceding figures.
|
|
Caffeine abrogates the G2 delay resulting from irradiation
(31) and leads to increased nuclear p34Cdc2 activity (Fig.
4B, lanes 5 and 6). We examined the
location of tyrosine 15-phosphorylated p34Cdc2 after
caffeine treatment. Synchronized HeLa cells were treated with radiation
or etoposide with or without caffeine and harvested 16 h after
release from the G1/S block. Harvested samples were fractionated into cytoplasmic and nuclear components and probed for
phosphotyrosine 15 p34Cdc2 protein (Fig. 5B).
Nocodazole-treated cells, serving as controls, as expected showed no
tyrosine 15-phosphorylated p34Cdc2 protein. In contrast,
both radiation or etoposide treatment led to marked nuclear
accumulation and minimal cytoplasmic accumulation of tyrosine
15-phosphorylated p34Cdc2. Caffeine substantially reduced
tyrosine 15-phosphorylated p34Cdc2 protein accumulation
after radiation and etoposide treatment. The blot was then stripped and
reprobed for total (both phosphorylated and unphosphorylated)
p34Cdc2 protein. This showed that total p34Cdc2
protein was comparable in amounts in the cytoplasm and nucleus under
all treatment conditions, suggesting that there was no marked redistribution of protein. Progression into mitosis was measured for
cells under the treatment conditions described in Fig. 5B, and the results are shown in Fig. 5C. In each case,
inhibition of progression into mitosis was associated with high levels
of nuclear tyrosine-phosphorylated p34Cdc2.
Radiation Dose-dependent Accumulation of Tyrosine
15-phosphorylated p34Cdc2 Protein after DNA
Damage--
The dose dependence of nuclear accumulation of tyrosine
15-phosphorylated p34Cdc2 protein after irradiation was
determined. Synchronized cells were mocked-irradiated or irradiated
with 2, 5, or 10 Gy (Fig. 6). All cells
were harvested at 15 h after release from the G1/S block. Cells treated with 10 Gy showed the greatest accumulation, whereas cells treated with 2 Gy showed less but still an appreciable accumulation of phosphotyrosine 15 p34Cdc2 protein.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 6.
Radiation dose-dependent
accumulation of tyrosine 15-phosphorylated p34Cdc2 protein
after DNA damage. HeLa cells were grown, and lysates were prepared
as described in Fig. 5. Synchronized cells were mock-irradiated
(No IR) or irradiated (IR) with 2, 5, or 10 Gy
3 h after release. Cells treated with nocodazole (20 µg/ml)
(Noc) 3 h after release served as the negative control.
All cells were harvested at the same time, 15 h after release. The
nuclear fractions were isolated for immunoblotting.
|
|
In summary, treatment of HeLa cells by radiation leads to nuclear
accumulation of tyrosine 15-phosphorylated p34Cdc2
concomitant with G2 delay, and caffeine abrogates both the
cell cycle delay as well as the accumulation of tyrosine
15-phosphorylated p34Cdc2.
 |
DISCUSSION |
In this report, we showed that the induced expression of either
cyclin B1 or Cdc2AF increased p34Cdc2 kinase activity after
irradiation, but that the restoration of activity failed to result in
cell cycle progression. The barrier appears to lie in localization of
the activity within the cell. The increased p34Cdc2
activity was initially confined to the cytoplasm. These results indicated that exclusion of p34Cdc2 kinase activity from
the nucleus may contribute to the cell cycle delay after radiation in
addition to contributing to the availability of cyclin B1 and
phosphorylation of p34Cdc2.
These results are in accord with and give further insight into a number
of previous observations. In the report of Jin et al. (27),
expression of Cdc2AF in HeLa cells only partially reversed the
G2 delay after irradiation, despite the rapid induction of
substantial p34Cdc2 kinase activity to amounts greater than
those in unirradiated cells. In this report, we confirm that
p34Cdc2 kinase activity is increased by Cdc2AF expression,
but we found that the increased activity was not in the nucleus. The
delay in the appearance of p34Cdc2 activity in the nucleus
or repression of nuclear p34Cdc2 kinase activity may
account for the residual G2 delay. These results are quite
similar to results obtained by restoring cyclin B1 protein in
irradiated HeLa cells. Increased cyclin B1 resulted in increased total
p34Cdc2 activity, yet the p34Cdc2 activity was
also initially restricted to the cytoplasm, consistent with the
observation that increased cyclin B1 only partially abrogated the
G2 block in HeLa cells. p34Cdc2 activity is
reduced by radiation, but even high levels of p34Cdc2
cytoplasmic activity are not sufficient to eliminate the G2 block.
Sluder et al. (41) have found evidence of cytoplasmic and
nuclear compartmentalization of p34Cdc2 kinase activity in
sea urchin zygotes. Pronuclear fusion in these cells is normally marked
by the synchronous dissolution of both the sperm and egg nuclei.
However, pretreatment of sperm or egg nuclei with ultraviolet light or
psoralen to damage the DNA prevented nuclear membrane dissolution of
the treated nuclei despite high levels of cytoplasmic
p34Cdc2 kinase activity. Similarly, treatment of HeLa cells
with a dose of etoposide, which leads to profound cell cycle block, led
to cytoplasmic accumulation of levels of p34Cdc2 histone H1
kinase activity comparable with control untreated cells (42) without
cell cycle progression. Lock (18) also found high levels of
p34Cdc2 activity in HeLa cells treated with etoposide at a
time when they remain blocked from cell cycle progression.
Heald et al. (37) found evidence of cytoplasmic-nuclear
compartmentalization in baby hamster kidney cells. Transfection of the
catalytic domain of Wee1, which is known to phosphorylate and thus
inhibit p34Cdc2, inhibited the onset of mitosis but,
paradoxically, led to 5- to 20-fold increase in histone H1 kinase
activity. The increased kinase activity appeared to be localized to the
cytoplasm, suggesting that the nucleus was protected from the
inappropriately high kinase activity (37). These observations, as well
as our results, do not exclude the possibility that DNA damage may
raise the threshold level of cytoplasmic p34Cdc2 activity
that is required to dissolve the nuclear membrane and initiate mitosis
or the possibility of a DNA damage-inducible inhibitor.
The regulation of nuclear p34Cdc2 activity could occur at
the level of cyclin B1, p34Cdc2 phosphorylation, or both or
possibly involve an inhibitor. Expression of Gadd45, a damage-inducible
gene, may inhibit cyclin B1-p34Cdc2 activity (48). Exclusion of
cyclin B1 from the nucleus could prevent nuclear p34Cdc2
activity. Cyclin B1 contains a sequence, the cytoplasmic retention signal (CRS), which confers a degree of cell
cycle-dependent localization (Pines and Hunter (34)). The
CRS has been shown to be a CRM-1-dependent nuclear export
signal. Cyclin B1 is localized in the cytoplasm until just before the
onset of mitosis, when retention in the nucleus is accompanied by
phosphorylation and inactivation of the nuclear export signal. Nuclear
cyclin B1 becomes evident as cells progress from G2 to
mitosis in normally cycling cells, accompanied by phosphorylation of
the cytoplasmic retention signal (29). Li et al. (29) showed
that although phosphorylation of cyclin B1 is not required for its
binding to p34Cdc2 or induction of p34Cdc2
kinase activity, cyclin B1 appears to be compartmentalized through the
normal cell cycle, and regulation of that compartmentalization by
phosphorylation may contribute to the radiation-induced G2 delay and localization of p34Cdc2 activity.
What is the role of nuclear localization of cyclin B1 in regulating the
G2 delay induced by DNA damage? Jin et al. (38) recently reported that the expression of Cdc2AF together with the
transfection of a vector expressing cyclin B1 in which a nuclear localization signal has been placed (to counteract the CRS) completely abrogated the G2 delay after irradiation, whereas neither
the cyclin B1 nuclear localization signal nor Cdc2AF by itself had such
an effect. However, although the cells exited G2, this was not a normal cell cycle progression but instead resulted in mitotic catastrophe. Toyoshima et al. (30) have found that
microinjection of HeLa cells treated with etoposide with mutant cyclin
B1 protein that contains a defective CRS and hence remains localized in
the nucleus still manifest a profound G2 delay. These data
indicate that translocation of cyclin B1 into the nucleus is not
sufficient to effect the transition into mitosis. As suggested by Jin
et al. (38), it is plausible that the nuclear localization
signal cyclin B1 bypasses the compartmentalization of
p34Cdc2 kinase activity by driving cytoplasmic kinase
activity into the nucleus. Since cyclin B1 localization is controlled
by its phosphorylation, it remains an intriguing possibility that
cyclin B1-directed kinases regulate cyclin B-p34Cdc2
localization and are modulated by checkpoint pathways (44). Our finding
of significant levels of cyclin B1-p34Cdc2 activity
persisting in the cytoplasm after exposure to DNA-damaging agents
underscore the complexity of this regulation. Thus cyclin B1
availability and location potentially affect the G2 delay. In addition, p34Cdc2 activity is also inhibited after
irradiation. It has been previously reported that DNA damage leads to
tyrosine phosphorylation of p34Cdc2 (18, 24, 45, 54-58).
DNA damage has been reported to up-regulate Wee1 kinase activity, a
kinase that leads to p34Cdc2 inactivation by tyrosine
phosphorylation (45, 46). However, other reports have found that
radiation does not have an effect on Wee1 kinase (47), suggesting that
the regulation of Wee1 kinase activity may be cell type-specific or
that other inhibitory kinases may exist.
The phosphorylation of p34Cdc2 is also controlled by the
phosphatase Cdc25C, which activates p34Cdc2 by removing the
inhibitory phosphorylation (49). Cdc25C in turn may be inhibited by
Chk1, a protein kinase that is activated by DNA damage (28, 50-52). It
has recently been reported that ionizing radiation results in exclusion
of Cdc25 from the nucleus in fission yeast, mediated by association of
Cdc25 protein with Rad24 protein, the latter of which acts as a nuclear
export sequence (53). It remains to be seen whether similar effects are
noted in human cells. Nonetheless, the exclusion of both cyclin B1 and Cdc25 protein from the nucleus after exposure to DNA-damaging agents
underscores the central importance of nuclear localization of factors
necessary for cell cycle progression in mediating progression through
the G2 delay after DNA damage.
We noted that tyrosine-phosphorylated p34Cdc2 is
predominantly localized to the nucleus. It is possible that nuclear
localization of p34Cdc2 (with or without its cyclin B1
partner) may first require tyrosine 15 or threonine 14 phosphorylation.
Nuclear localization signals have frequently been found to be regulated
by phosphorylation. Boulikas (59) found that most nonmembrane
serine/threonine protein kinases, including Cdc2, contain karyophilic
and acidic clusters of amino acids and has proposed that this may serve
as a weak nuclear localization signal, perhaps in conjunction with
transporter proteins. The inability of Cdc2AF to completely abolish the
cell cycle delay after radiation may be related to delayed entry into the nucleus; we are currently investigating this possibility.
Other cyclins that are present in substantial quantities during the
G2 to M transition include cyclin A and B2. Cyclin A is constitutively nuclear (60). The CRS is conserved between cyclin B1 and
B2, but there are significant differences in their localization patterns. Human cyclin B2 appears to colocalize with the Golgi apparatus and remains in the cytoplasm even as cells enter prophase and
cyclin B1 precipitously relocates into the nucleus (34, 62). The roles
cyclin A-p34Cdc2 and cyclin B2-p34Cdc2 play in
the checkpoint response remain to be determined.
DNA damage results in cell cycle block and regulation of
p34Cdc2 activity in a wide range of cell types. Several
mechanisms have now been identified for this block, including cyclin B1
levels, p34Cdc2 phosphorylation, and localization of
p34Cdc2 activity as distinct but overlapping mechanisms
that result in cell cycle block after DNA damage. In this report, we
find that induction of cyclin B1, introduction of the constitutively
active form of cyc2AF, or both only partially reverse the
radiation-induced G2 delay. Our findings that
p34Cdc2 activity is compartmentalized help explain the
inability of these maneuvers to completely abrogate the block. Cyclin
B1 expression can markedly stimulate the kinase activity, but that
activity is confined to the cytoplasmic compartment. Taken together,
these results suggest that the increased kinase activity is in itself ineffectual in initiating mitosis and that altered compartmentalization of p34Cdc2 activity may contribute to the cell cycle delays
following exposure to ionizing radiation in HeLa cells. These results
suggest a revised model of cell cycle progression in which cyclin
B1-p34Cdc2 kinase activity is initially diminished but also
initially confined to the cytoplasm after exposure of HeLa cells to
DNA-damaging agents, including during the G2 delay. The
portion of p34Cdc2 that is nuclear is maintained in an
inactive state by tyrosine phosphorylation. Progression into mitosis
occurs when nuclear activity becomes evident. Further work will be
required to fully characterize the mechanisms that regulate this activity.
 |
ACKNOWLEDGEMENTS |
We thank Karen Chang and Yi Cheng for superb
technical assistance and Dr. Frank McKeon for the gift of the pECE-Cdc2
and pECE-Cdc2AF plasmids.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants GM 47439 and CA 751138 (to R. J. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§
To whom correspondence should be addressed: Rm. 269 John Morgan
Bld., Dept. of Pathology, 36 and Hamilton Walk, University of
Pennsylvania, Philadelphia, PA 19104. Tel.: 215-898-8401; Fax: 215-573-4243; E-mail: muschel@mail.med.upenn.edu.
 |
ABBREVIATIONS |
The abbreviations used are:
Gy, gray;
MOPS, 3-(N-morpholino)propanesulfonic acid;
CRS, cytoplasmic
retention signal.
 |
REFERENCES |
| 1.
|
Lane, D.,
Midgley, D.,
Hupp, T.,
Lu, X.,
Vojtesek, B.,
and Picksley, S.
(1995)
Philos. Trans. R. Soc. Lond-Biol. Sci.
347,
83-87[Abstract/Free Full Text]
|
| 2.
|
Lydall, D.,
and Weinert, T.
(1996)
Curr. Opin. Genet. Dev.
6,
4-11[CrossRef][Medline]
[Order article via Infotrieve]
|
| 3.
|
Weinert, T.,
Kiser, G.,
and Hartwell, L.
(1994)
Genes Dev.
8,
652-665[Abstract/Free Full Text]
|
| 4.
|
Maity, A.,
McKenna, W. G.,
and Muschel, R. J.
(1994)
Radiother. Oncol.
31,
1-13[CrossRef][Medline]
[Order article via Infotrieve]
|
| 5.
|
Pellegata, N. S.,
Antoniono, R. J.,
Redpath, J. L.,
and Stanbridge, E. J.
(1996)
Proc. Natl. Acad Sci. U. S. A.
93,
15209-15214[Abstract/Free Full Text]
|
| 6.
|
El-Deiry, W.,
Tokino, T.,
Velculescu, V.,
Levy, D.,
Parson, R.,
Trent, J.,
Lin, D.,
Mercer, W.,
Kinzler, K.,
and Vogelstein, B.
(1993)
Cell
75,
817-825[CrossRef][Medline]
[Order article via Infotrieve]
|
| 7.
|
Harper, J. W.,
Adami, G. R.,
Wei, N.,
Keyomarsi, K.,
and Elledge, S. J.
(1993)
Cell
75,
805-816[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Kastan, M. B.,
Onyekwere, O.,
Sidransky, D.,
Vogelstein, B.,
and Craig, R. W.
(1991)
Cancer Res.
51,
6304-6311[Abstract/Free Full Text]
|
| 9.
|
Stewart, N.,
Hicks, G. G.,
Paraskevas, F.,
and Mowat, M.
(1995)
Oncogene
10,
109-115[Medline]
[Order article via Infotrieve]
|
| 10.
|
Xiong, Y.,
Hannon, G. J.,
Zhang, H.,
Casso, D.,
Kobayashi, R.,
and Beach, D.
(1993)
Nature
366,
701-704[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Munger, K.,
Scheffner, M.,
Huibregtse, J. M.,
and Howley, P. M.
(1992)
Cancer Surv.
12,
197-217[Medline]
[Order article via Infotrieve]
|
| 12.
|
Terasima, T.,
and Tolmach, L.
(1963)
Biophys. J.
3,
11-33
|
| 13.
|
Kastan, M. B.,
Zhan, Q.,
El-Deiry, W. S.,
Carrier, F.,
Jacks, T.,
Walsh, W. V.,
Plunkett, B. S.,
Vogelstein, B.,
and Fornace, A. J.
(1992)
Cell
71,
587-597[CrossRef][Medline]
[Order article via Infotrieve]
|
| 14.
|
Kaufmann, W. K.
(1998)
Proc. Soc. Exp. Biol. Med.
217,
327-334[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Levedakou, E. N.,
Kaufmann, W. K.,
Alcorta, D. A.,
Galloway, D. A.,
and Paules, R. S.
(1995)
Cancer Res.
55,
2500-2502[Abstract/Free Full Text]
|
| 16.
|
Slichenmyer, W. J.,
Nelson, W. G.,
Slebos, R. J.,
and Kastan, M. B.
(1993)
Cancer Res.
53,
4164-4168[Abstract/Free Full Text]
|
| 17.
|
Lock, R.,
and Ross, W.
(1990)
Cancer Res.
50,
3761-3766[Abstract/Free Full Text]
|
| 18.
|
Lock, R. B.
(1992)
Cancer Res.
52,
1817-1822[Abstract/Free Full Text]
|
| 19.
|
Metting, N. F.,
and Little, J. B.
(1995)
Radiat. Res.
143,
286-292[Medline]
[Order article via Infotrieve]
|
| 20.
|
Nishii, K.,
Kabarowski, J. H.,
Gibbons,
Griffiths, S. D.,
Titley, I.,
Wiedemann, L. M.,
and Greaves, M. F.
(1996)
Oncogene
13,
2225-2234[Medline]
[Order article via Infotrieve]
|
| 21.
|
O'Connor, P.,
Ferris, D.,
White, G.,
Pines, J.,
Hunter, T.,
Longo, D.,
and Kohn, K.
(1992)
Cell Growth Differ.
3,
43-52[Abstract]
|
| 22.
|
O'Connor, P. M.,
Ferris, D. K.,
Pagano, M.,
Draetta, G.,
Pines, J.,
Hunter, T.,
Longo, D. L.,
and Kohn, K. W.
(1993)
J. Biol. Chem.
268,
8298-8308[Abstract/Free Full Text]
|
| 23.
|
Smeets, M. F.,
Mooren, E. H.,
and Begg, A. C.
(1994)
Radiother. Oncol.
33,
217-227[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Tsao, Y.-P.,
D'Arpa, P.,
and Liu, L.
(1992)
Cancer Res.
52,
1823-1829[Abstract/Free Full Text]
|
| 25.
|
Bache, M.,
Dunst, J.,
Wurl, P.,
Frode, D.,
Meye, A.,
Schmidt, H.,
Rath, F. W.,
and Taubert, H.
(1999)
Anticancer Res.
19,
1827-1832[Medline]
[Order article via Infotrieve]
|
| 26.
|
Kao, G.,
McKenna, W.,
Maity, A.,
Blank, K.,
and Muschel, R.
(1997)
Cancer Res.
57,
753-758[Abstract/Free Full Text]
|
| 27.
|
Jin, P.,
Gu, Y.,
and Morgan, D. O.
(1996)
J. Cell Biol.
134,
963-970[Abstract/Free Full Text]
|
| 28.
|
Blasina, A.,
Paegle, E.,
and McGowan, C.
(1997)
Mol. Biol. Cell
8,
1013-1023[Abstract]
|
| 29.
|
Li, J.,
Meyer, A.,
and Donoghue, D.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
502-507[Abstract/Free Full Text]
|
| 30.
|
Toyoshima, F.,
Moriguchi, T.,
Wada, A.,
Fukuda, M.,
and Nishida, E.
(1998)
EMBO J.
17,
2728-2735[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Bernhard, E. J.,
Maity, A.,
Muschel, R. J.,
and McKenna, W. G.
(1994)
Radiat. Res.
140,
393-400[Medline]
[Order article via Infotrieve]
|
| 32.
|
Muschel, R. J.,
Zhang, H. B.,
Iliakis, G.,
and McKenna, W. G.
(1991)
Cancer Res.
51,
5113-5117[Abstract/Free Full Text]
|
| 33.
|
Schreiber, E.,
Matthias, P.,
Muller, M.,
and Schaffner, W.
(1989)
Nucleic Acids Res.
17,
6419[Free Full Text]
|
| 34.
|
Pines, J.,
and Hunter, T.
(1994)
EMBO J.
13,
3772-3781[Medline]
[Order article via Infotrieve]
|
| 35.
|
Sherwood, S.,
Rush, D.,
Kung, A.,
and Schimke, R.
(1994)
Exp. Cell Res.
211,
275-281[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Moore, M. S.,
and Blobel, G.
(1994)
Trends Biochem. Sci.
19,
211-216[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Heald, R.,
McLoughlin, M.,
and McKeon, F.
(1993)
Cell
74,
463-474[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Jin, P.,
Hardy, S.,
and Morgan, D.
(1998)
J. Cell Biol.
141,
875-885[Abstract/Free Full Text]
|
| 39.
|
Krek, W.,
and Nigg, E. A.
(1991)
EMBO J.
10,
3331-3341[Medline]
[Order article via Infotrieve]
|
| 40.
|
Maity, A.,
McKenna, W. G.,
and Muschel, R. J.
(1995)
EMBO J.
14,
603-609[Medline]
[Order article via Infotrieve]
|
| 41.
|
Sluder, G.,
Thompson, E. A.,
Rieder, C. L.,
and Miller, F. J.
(1995)
J. Cell Biol.
129,
1447-1458[Abstract/Free Full Text]
|
| 42.
|
Barratt, R.,
Kao, G.,
McKenna, W. G.,
Kuang, J.,
and Muschel, R. J.
(1998)
Cancer Res.
58,
2639-2645[Abstract/Free Full Text]
|
| 43.
|
Brown, A. L.,
Lee, C. H.,
Schwarz, J. K.,
Mitiku, N.,
Piwnica-Worms, H.,
and Chung, J. H.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
3745-3750[Abstract/Free Full Text]
|
| 44.
|
Moore, J. D.,
Yang, J.,
Truant, R.,
and Kornbluth, S.
(1999)
J. Cell Biol.
144,
213-224[Abstract/Free Full Text]
|
| 45.
|
Rhind, N.,
Furnari, B.,
and Russell, P.
(1997)
Genes Dev.
11,
504-511[Abstract/Free Full Text]
|
| 46.
| Yu, L., Orlandi, L., Wang, P., Krawchuk, D., Rucker, K., and O'Connor,
P. M. (1998) The 89th Annual Meeting of the American
Association for Cancer Research, New Orleans, 1219
|
| 47.
|
Tuel-Ahlgren, L.,
Jun, X.,
Waddick, K.,
Jin, J.,
Bolen, J.,
and Uckun, F.
(1996)
Leuk. Lymphoma
20,
417-426[Medline]
[Order article via Infotrieve]
|
| 48.
|
Zhan, Q.,
Antinore, M. J.,
Wang, X. W.,
Carrier, F.,
Smith, M. L.,
Harris, C. C.,
and Fornace, A. J., Jr.
(1999)
Oncogene
18,
2892-2900[CrossRef][Medline]
[Order article via Infotrieve]
|
| 49.
|
Barth, H.,
Hoffman, I.,
and Kinzel, V.
(1996)
Cancer Res.
56,
2268-2272[Abstract/Free Full Text]
|
| 50.
|
O'Connell, M. J.,
Raleigh, J. M.,
Verkade, H. M.,
and Nurse, P.
(1997)
EMBO J.
16,
545-554[CrossRef][Medline]
[Order article via Infotrieve]
|
| 51.
|
Sanchez, Y.,
Wong, C.,
Thoma, R. S.,
Richman, R.,
Wu, Z.,
Piwnica-Worms, H.,
and Elledge, S. J.
(1997)
Science
277,
1497-1501[Abstract/Free Full Text]
|
| 52.
|
Walworth, N.,
Davey, S.,
and Beach, D.
(1993)
Nature
363,
368-371[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Lopez-Girona, A.,
Furnari, B.,
Mondesert, O.,
and Russell, P.
(1999)
Nature
397,
172-175[CrossRef][Medline]
[Order article via Infotrieve]
|
| 54.
|
David-Pfeuty, T.,
and Nouvian-Dooghe, Y.
(1997)
Cancer Res.
57,
4482-4487[Abstract/Free Full Text]
|
| 55.
|
Herzinger, T.,
Funk, J. O.,
Hillmer, K.,
Eick, D.,
Wolf, D. A.,
and Kind, P.
(1995)
Oncogene
11,
2151-2156[Medline]
[Order article via Infotrieve]
|
| 56.
|
Kharbanda, S.,
Saleem, A.,
Datta, R.,
Yuan, Z. M.,
Weichselbaum, R.,
and Kufe, D.
(1994)
Cancer Res.
54,
1412-1414[Abstract/Free Full Text]
|
| 57.
|
Paules, R. S.,
Levedakou, E. N.,
Wilson, S. J.,
Innes, C. L.,
Rhodes, N.,
Tlsty, T. D.,
Galloway, D. A.,
Donehower, L. A.,
Tainsky, M. A.,
and Kaufmann, W. K.
(1995)
Cancer Res.
55,
1763-1773[Abstract/Free Full Text]
|
| 58.
|
Shimizu, T.,
O'Connor, P. M.,
Kohn, K. W.,
and Pommier, Y.
(1995)
Cancer Res.
55,
228-231[Abstract/Free Full Text]
|
| 59.
|
Boulikas, T.
(1996)
J. C. Biochem.
60,
61-82
|
| 60.
|
Pines, J.,
and Hunter, T.
(1991)
J. Cell Biol.
115,
1-17[Abstract/Free Full Text]
|
| 61.
|
Flaggs, G.,
Plug, A. W.,
Dunks, K. M.,
Mundt, K. E.,
Ford, J. C.,
Quiggle, M. R.,
Taylor, E. M.,
Westphal, C. H.,
Ashley, T.,
Hoekstra, M. F.,
and Carr, A. M.
(1997)
Curr. Biol.
7,
977-986[CrossRef][Medline]
[Order article via Infotrieve]
|
| 62.
|
Jackman, M.,
Firth, M.,
and Pines, J.
(1995)
EMBO J.
14,
1646-1654[Medline]
[Order article via Infotrieve]
|
| 63.
|
Furnari, B.,
Rhind, N.,
and Russell, P.
(1997)
Science
277,
1495-1497[Abstract/Free Full Text]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C.-C. Chang, J. D. Heller, J. Kuo, and R. C. C. Huang
Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression
PNAS,
September 7, 2004;
101(36):
13239 - 13244.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fletcher, Y. Cheng, and R. J. Muschel
Abolishment of the Tyr-15 Inhibitory Phosphorylation Site on cdc2 Reduces the Radiation-induced G2 Delay, Revealing a Potential Checkpoint in Early Mitosis
Cancer Res.,
January 1, 2002;
62(1):
241 - 250.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1999 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|